DE69841766D1 - Antimitotisches halogeniertes Derivat eines Vinca- Alkaloids - Google Patents

Antimitotisches halogeniertes Derivat eines Vinca- Alkaloids

Info

Publication number
DE69841766D1
DE69841766D1 DE69841766T DE69841766T DE69841766D1 DE 69841766 D1 DE69841766 D1 DE 69841766D1 DE 69841766 T DE69841766 T DE 69841766T DE 69841766 T DE69841766 T DE 69841766T DE 69841766 D1 DE69841766 D1 DE 69841766D1
Authority
DE
Germany
Prior art keywords
antimitotic
vinca alkaloid
halogenated derivative
formula
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69841766T
Other languages
German (de)
English (en)
Inventor
Alain Duflos
Jacques Fahy
Du Boullay Valerie Thillaye
Jean-Marc Barret
Bridget Hill
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PIERRE FABRE MEDICAMENT PRODUC
Pierre Fabre Medicament SA
Original Assignee
PIERRE FABRE MEDICAMENT PRODUC
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PIERRE FABRE MEDICAMENT PRODUC, Pierre Fabre Medicament SA filed Critical PIERRE FABRE MEDICAMENT PRODUC
Application granted granted Critical
Publication of DE69841766D1 publication Critical patent/DE69841766D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/04Dimeric indole alkaloids, e.g. vincaleucoblastine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
DE69841766T 1997-04-10 1998-04-10 Antimitotisches halogeniertes Derivat eines Vinca- Alkaloids Expired - Lifetime DE69841766D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9704398A FR2761990B1 (fr) 1997-04-10 1997-04-10 Derives halogenes antimitotiques d'alcaloides de vinca

Publications (1)

Publication Number Publication Date
DE69841766D1 true DE69841766D1 (de) 2010-08-26

Family

ID=9505731

Family Applications (3)

Application Number Title Priority Date Filing Date
DE69841766T Expired - Lifetime DE69841766D1 (de) 1997-04-10 1998-04-10 Antimitotisches halogeniertes Derivat eines Vinca- Alkaloids
DE69824840T Expired - Lifetime DE69824840T2 (de) 1997-04-10 1998-04-10 Antimitotische halogenierte derivate von vinca alkaloiden
DE122010000054C Pending DE122010000054I1 (de) 1997-04-10 1998-04-10 Antimitotisches halogeniertes Derivat eines Vinca- Alkaloids

Family Applications After (2)

Application Number Title Priority Date Filing Date
DE69824840T Expired - Lifetime DE69824840T2 (de) 1997-04-10 1998-04-10 Antimitotische halogenierte derivate von vinca alkaloiden
DE122010000054C Pending DE122010000054I1 (de) 1997-04-10 1998-04-10 Antimitotisches halogeniertes Derivat eines Vinca- Alkaloids

Country Status (15)

Country Link
US (1) US6127377A (https=)
EP (3) EP1357125A3 (https=)
JP (3) JP4401440B2 (https=)
AT (2) ATE270297T1 (https=)
AU (1) AU737549C (https=)
BR (2) BR9807944B1 (https=)
CA (3) CA2455416C (https=)
CY (2) CY1111476T1 (https=)
DE (3) DE69841766D1 (https=)
DK (2) DK1764368T3 (https=)
ES (2) ES2347878T3 (https=)
FR (2) FR2761990B1 (https=)
LU (1) LU91769I2 (https=)
PT (2) PT975640E (https=)
WO (1) WO1998045301A1 (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2761990B1 (fr) * 1997-04-10 1999-06-25 Pf Medicament Derives halogenes antimitotiques d'alcaloides de vinca
US6890558B2 (en) * 2002-05-31 2005-05-10 R.P. Scherer Technologies, Inc. Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment
WO2005055939A2 (en) * 2003-12-04 2005-06-23 Amr Technology, Inc. Vinca derivatives
WO2005055943A2 (en) * 2003-12-04 2005-06-23 Amr Technology, Inc. Vinorelbine derivatives
FR2863891B1 (fr) * 2003-12-23 2006-03-24 Pf Medicament Composition pharmaceutique de vinflunine destinee a une administration parentale, procede de preparation et utilisation
US20110015221A1 (en) * 2003-12-23 2011-01-20 Pierre Fabre Medicament Pharmaceutical composition of vinflunine which is intended for parenteral administration preparation method thereof and use of same
US7772177B2 (en) 2005-05-18 2010-08-10 Aegera Therapeutics, Inc. BIR domain binding compounds
FR2894966B1 (fr) 2005-12-20 2008-03-14 Pierre Fabre Medicament Sa Nouvelle forme cristalline de la vinflunine
AU2007250443B2 (en) 2006-05-16 2013-06-13 Pharmascience Inc. IAP BIR domain binding compounds
US20080125451A1 (en) * 2006-09-12 2008-05-29 Amr Technology, Inc. Vinorelbine derivatives
US8039453B2 (en) * 2006-09-12 2011-10-18 Albany Molecular Research, Inc. Vinca derivatives
FR2905949B1 (fr) * 2006-09-20 2008-11-21 Pierre Fabre Medicament Sa Derives fluores de catharanthine, leur preparation et leur utilisation comme precurseurs d'alcaloides dimeres de vinca
FR2910812B1 (fr) 2006-12-29 2009-03-20 Pierre Fabre Medicament Sa Compositions pharmaceutiques injectables lyophilisees de derives hemi-synthetiques d'alcaloide de vinca stables a temperature ambiante
FR2912406B1 (fr) * 2007-02-13 2009-05-08 Pierre Fabre Medicament Sa Sels cristalins anhydres de vinflunine, procede de preparation et utilisation en tant que medicament et moyen de purification de la vinflunine.
FR2918567B1 (fr) * 2007-07-11 2012-08-03 Pf Medicament Composition pharmaceutique stable d'un sel hydrosoluble de vinorelbine.
FR2918566B1 (fr) * 2007-07-11 2009-10-09 Pierre Fabre Medicament Sa Composition pharmaceutique stable d'un sel hydrosoluble de vinflunine.
US20090076055A1 (en) * 2007-09-14 2009-03-19 Protia, Llc Deuterium-enriched vinflunine
DE102010020994B4 (de) * 2010-01-27 2022-01-27 Interpane Entwicklungs-Und Beratungsgesellschaft Mbh Verfahren zur Herstellung eines beschichteten Gegenstands mit Texturätzen
WO2011098904A1 (en) 2010-02-12 2011-08-18 Aegera Therapeutics, Inc. Iap bir domain binding compounds
WO2011103007A2 (en) * 2010-02-22 2011-08-25 The Scripps Research Institute 10'-fluorinated vinca alkaloids provide enhanced biological activity against mdr cancer cells
WO2026064527A1 (en) 2024-09-19 2026-03-26 Tesseract Medicines Us, Llc Kras-targeting covalent-induced drug conjugates comprising a tubulin inhibitor payload
WO2026064520A1 (en) 2024-09-19 2026-03-26 Tesseract Medicines Us, Llc Covalent-induced drug conjugates targeting kras and comprising a tubulin inhibitor payload

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2707988B1 (fr) * 1993-07-21 1995-10-13 Pf Medicament Nouveaux dérivés antimitotiques des alcaloïdes binaires du catharantus rosesus, leur procédé de préparation et les compositions pharmaceutiques les comprenant.
FR2761990B1 (fr) * 1997-04-10 1999-06-25 Pf Medicament Derives halogenes antimitotiques d'alcaloides de vinca

Also Published As

Publication number Publication date
CA2455416A1 (fr) 1998-10-15
CA2286560A1 (fr) 1998-10-15
CY1111476T1 (el) 2012-01-25
BR9816177B1 (pt) 2010-08-24
EP1764368A1 (fr) 2007-03-21
FR10C0045I1 (https=) 2010-10-29
CA2665949A1 (fr) 1998-10-15
DK0975640T3 (da) 2004-11-01
CA2455416C (fr) 2010-11-02
EP1764368B1 (fr) 2010-07-14
JP2004277418A (ja) 2004-10-07
DE69824840T2 (de) 2005-07-21
JP4307292B2 (ja) 2009-08-05
CA2665949C (fr) 2013-06-11
CY2010019I2 (el) 2012-01-25
JP2001518892A (ja) 2001-10-16
AU7340898A (en) 1998-10-30
PT1764368E (pt) 2010-09-16
CY2010019I1 (el) 2012-01-25
ATE270297T1 (de) 2004-07-15
ATE473987T1 (de) 2010-07-15
CA2286560C (fr) 2009-09-08
EP1357125A3 (fr) 2003-11-26
LU91769I2 (fr) 2011-02-22
AU737549B2 (en) 2001-08-23
ES2347878T3 (es) 2010-11-22
EP1357125A2 (fr) 2003-10-29
PT975640E (pt) 2004-11-30
JP4401440B2 (ja) 2010-01-20
DE69824840D1 (de) 2004-08-05
EP0975640B1 (fr) 2004-06-30
BR9807944B1 (pt) 2011-02-08
EP0975640A1 (fr) 2000-02-02
US6127377A (en) 2000-10-03
FR10C0045I2 (fr) 2011-04-29
BR9807944A (pt) 2000-03-08
JP2009167196A (ja) 2009-07-30
DE122010000054I1 (de) 2011-05-05
AU737549C (en) 2002-03-28
ES2222588T3 (es) 2005-02-01
DK1764368T3 (da) 2010-10-18
WO1998045301A1 (fr) 1998-10-15
FR2761990A1 (fr) 1998-10-16
FR2761990B1 (fr) 1999-06-25

Similar Documents

Publication Publication Date Title
DE69841766D1 (de) Antimitotisches halogeniertes Derivat eines Vinca- Alkaloids
YU97292A (sh) N-fenilalanil i n-fenilglicil derivati dipeptida l-azetidin-2-karboksilne kiseline
SE7508332L (sv) Sett att framstella 3-kinolin-karboxylsyraderivat och anvendning derav som lekemedel.
AU557094B2 (en) 9-(2-(3-indolyl)ethyl)-1-oxa-4,9-diazaspiro(5,5)undecan 3-ones
IT1248743B (it) Metodo per la preparazione, in una forma non-racemica, di derivati della furo <3,4-c> piridina
ATE29721T1 (de) 5-(4-vinyl- oder 4-ethynylbenzoyl)-1,2-dihydro-3h-pyrrolo-(1,2-a -pyrrol-1-carbosaeure und deren derivate.
ES532836A0 (es) Metodo para preparar derivados de acidos b-carbolin-3-barboxilicos
GR861782B (en) Method for preparing n-methyl derivatives of ergoline
HUT40090A (en) New process for production of derivatives of hh-1,2,4-triasole
US4122081A (en) 5'-Hydroxyleurosine and related compounds
DE3873786D1 (de) Substituierte 1,3,4,9-tetrahydropyrano(3,4-b)indol-1-essigsaeuren.
JPS5520723A (en) Preparation of cephalosporin compound
ATA71691A (de) Neue thiophen-2-carbonsaeurederivate und verfahren zu deren herstellung
JPS5759896A (en) Production of thiazolineazetidinone derivative
US4175080A (en) Process of producing 5'-hydroxyleurosine and related compounds
KR950032210A (ko) 8-아미노-10-(아자비사이클로알킬)-피리도[1,2,3-d,e][1,3,4] 벤족사디아진유도체
US4379936A (en) Nortropane derivatives
JPS5718680A (en) Indole derivative
JPS57136586A (en) Cephalosporin derivative and its preparation
JPS51113890A (en) Method for preparing novel cephalosporins
SE7612319L (sv) Forfarande for framstellning av bensomorfanderivat.
JPS54148750A (en) Novel halogenoacetanilide derivative and its preparation
UA6324A1 (uk) Спосіб одержання похідних 6-фтор-1, дігідро-4-оксо-7-заміщений піперазінілхінолін-3-карбонової кислоти або їх фармацевтично прийнятних солей
JPS5246097A (en) Method of preparing pyrrlobenzodiazpins or acid addition salts thereof

Legal Events

Date Code Title Description
R067 Examining division decision granting supplementary protection certificate

Free format text: PRODUCT NAME: VINFLUNIN-DITARTRAT; REGISTRATION NO/DATE: EU/1/09/550/001-012 20090921

Spc suppl protection certif: 122010000054

Filing date: 20101221

Expiry date: 20180411

Extension date: 20230410

R069 Supplementary protection certificate granted

Free format text: PRODUCT NAME: VINFLUNIN-DITARTRAT; REGISTRATION NO/DATE: EU/1/09/550/001-012 20090921

Spc suppl protection certif: 122010000054

Filing date: 20101221

Expiry date: 20180411

Extension date: 20230410